EUR 1.76
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 3.64 Million EUR | -5.91% |
2022 | 3.93 Million EUR | 60.29% |
2021 | 2.48 Million EUR | -17.44% |
2020 | 3.05 Million EUR | -8.91% |
2019 | 3.26 Million EUR | 63.84% |
2018 | 1.96 Million EUR | 23.99% |
2017 | 1.58 Million EUR | -58.62% |
2016 | 3.82 Million EUR | 59.28% |
2015 | 2.49 Million EUR | -28.88% |
2014 | 3.37 Million EUR | -1.08% |
2013 | 3.41 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 817.39 Thousand EUR | -22.4% |
2024 Q2 | 817.39 Thousand EUR | 0.0% |
2023 Q1 | 770.13 Thousand EUR | -59.4% |
2023 Q4 | 1.05 Million EUR | 0.0% |
2023 FY | - EUR | -2.72% |
2023 Q2 | 1.61 Million EUR | 109.7% |
2023 Q3 | 1.05 Million EUR | -34.78% |
2022 Q1 | 1.02 Million EUR | -23.7% |
2022 FY | - EUR | 60.29% |
2022 Q4 | 1.89 Million EUR | 162.96% |
2022 Q3 | 721.33 Thousand EUR | -63.22% |
2022 Q2 | 1.96 Million EUR | 91.34% |
2021 Q2 | 1.07 Million EUR | 150.8% |
2021 Q4 | 1.34 Million EUR | 137.27% |
2021 Q1 | 428.57 Thousand EUR | -74.51% |
2021 Q3 | 566.18 Thousand EUR | -47.32% |
2021 FY | - EUR | -17.44% |
2020 Q2 | 1.23 Million EUR | 133.02% |
2020 FY | - EUR | -8.91% |
2020 Q1 | 531.22 Thousand EUR | -68.43% |
2020 Q3 | 756.3 Thousand EUR | -38.9% |
2020 Q4 | 1.68 Million EUR | 122.28% |
2019 Q2 | 1.53 Million EUR | 122.15% |
2019 Q4 | 1.68 Million EUR | 123.33% |
2019 FY | - EUR | 63.84% |
2019 Q1 | 690.08 Thousand EUR | 28.44% |
2019 Q3 | 753.36 Thousand EUR | -50.86% |
2018 FY | - EUR | 23.99% |
2018 Q4 | 537.28 Thousand EUR | 0.0% |
2018 Q3 | 537.28 Thousand EUR | 18.4% |
2018 Q2 | 453.8 Thousand EUR | 0.0% |
2018 Q1 | 453.8 Thousand EUR | 77.82% |
2017 Q1 | 563.17 Thousand EUR | -44.47% |
2017 Q2 | 563.17 Thousand EUR | -0.0% |
2017 FY | - EUR | -58.62% |
2017 Q4 | 255.2 Thousand EUR | 0.0% |
2017 Q3 | 255.2 Thousand EUR | -54.68% |
2016 Q1 | 935.79 Thousand EUR | 80.31% |
2016 Q3 | 1.01 Million EUR | 8.38% |
2016 Q4 | 1.01 Million EUR | 0.0% |
2016 FY | - EUR | 59.28% |
2016 Q2 | 935.79 Thousand EUR | -0.0% |
2015 Q1 | 886.11 Thousand EUR | -15.25% |
2015 Q4 | 518.98 Thousand EUR | 7.03% |
2015 Q3 | 484.88 Thousand EUR | -20.82% |
2015 Q2 | 612.38 Thousand EUR | -30.89% |
2015 FY | - EUR | -28.88% |
2014 Q2 | 574.93 Thousand EUR | -23.48% |
2014 Q3 | 975.81 Thousand EUR | 69.73% |
2014 Q4 | 1.04 Million EUR | 7.15% |
2014 FY | - EUR | -1.08% |
2014 Q1 | 751.33 Thousand EUR | -23.86% |
2013 Q3 | 936.28 Thousand EUR | 13.09% |
2013 Q2 | 827.95 Thousand EUR | 20.4% |
2013 Q4 | 986.8 Thousand EUR | 5.4% |
2013 FY | - EUR | 0.0% |
2013 Q1 | 687.66 Thousand EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Evrofarma SA | 5.31 Million EUR | 31.346% |
Kri-Kri Milk Industry S.A. | 45.96 Million EUR | 92.065% |
Loulis Food Ingredients S.A. | 19.85 Million EUR | 81.632% |